Evolution of a fatal septic arthritis caused by a Panton-Valentine leukocidin (PVL)-producing Staphylococcus aureus strain. 2013

Mostafa Rafai, and Khalil Abouelalaa, and Yassine Skhsoukh, and Hicham Balkhi, and Lahcen Belyamani, and M'barek Dimou
Pole of medical and surgical emergencies, Military Hospital of Instruction Mohammed V, CHU Ibn Sina, Rabat, Morocco. Electronic address: mostafarafai@hotmail.fr.

We report the observation of a septic arthritis of the knee complicated within first 36 hours by multiorgan failure including acute respiratory distress syndrome (ARDS), heart failure, acute renal failure and disseminated intravascular coagulation (DIC). A diagnosis of staphylococcal arthritis was suspected confirmed by direct examination, and culture showed a Staphylococcus aureus sensitive to methicillin. The sample sent to the National Reference Centre for Staphylococci (Lyon, France) for genetic analysis confirmed the isolate positive for the PVL gene expression. The fulminating evolution of a septic S. aureus arthritis in an otherwise healthy man should probably evoke the possibility of LPV strain. Anti-PLV antibiotics with anti-staphylococcal activity, such as clindamycin and linezolid should be started without waiting for typing of the S. aureus strain.

UI MeSH Term Description Entries
D007719 Knee Joint A synovial hinge connection formed between the bones of the FEMUR; TIBIA; and PATELLA. Superior Tibiofibular Joint,Joint, Knee,Joint, Superior Tibiofibular,Knee Joints,Superior Tibiofibular Joints,Tibiofibular Joint, Superior
D007956 Leukocidins Pore forming proteins originally discovered for toxic activity to LEUKOCYTES. They are EXOTOXINS produced by some pathogenic STAPHYLOCOCCUS and STREPTOCOCCUS that destroy leukocytes by lysis of the cytoplasmic granules and are partially responsible for the pathogenicity of the organisms. Leucocidin,Leukocidin,Leukocidin Proteins,Proteins, Leukocidin
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009102 Multiple Organ Failure A progressive condition usually characterized by combined failure of several organs such as the lungs, liver, kidney, along with some clotting mechanisms, usually postinjury or postoperative. MODS,Multiple Organ Dysfunction Syndrome,Organ Dysfunction Syndrome, Multiple,Organ Failure, Multiple,Failure, Multiple Organ,Multiple Organ Failures
D005098 Exotoxins Toxins produced, especially by bacterial or fungal cells, and released into the culture medium or environment. Exotoxin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001170 Arthritis, Infectious Arthritis caused by BACTERIA; RICKETTSIA; MYCOPLASMA; VIRUSES; FUNGI; or PARASITES. Arthritis, Bacterial,Arthritis, Septic,Arthritis, Viral,Arthritides, Bacterial,Arthritis, Suppurative,Bacterial Arthritides,Bacterial Arthritis,Infectious Arthritis,Suppurative Arthritis,Septic Arthritis,Viral Arthritis
D001427 Bacterial Toxins Toxic substances formed in or elaborated by bacteria; they are usually proteins with high molecular weight and antigenicity; some are used as antibiotics and some to skin test for the presence of or susceptibility to certain diseases. Bacterial Toxin,Toxins, Bacterial,Toxin, Bacterial
D013203 Staphylococcal Infections Infections with bacteria of the genus STAPHYLOCOCCUS. Infections, Staphylococcal,Staphylococcus aureus Infection,Staphylococcal Infection,Staphylococcus aureus Infections
D013211 Staphylococcus aureus Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.

Related Publications

Mostafa Rafai, and Khalil Abouelalaa, and Yassine Skhsoukh, and Hicham Balkhi, and Lahcen Belyamani, and M'barek Dimou
March 2005, The Pediatric infectious disease journal,
Mostafa Rafai, and Khalil Abouelalaa, and Yassine Skhsoukh, and Hicham Balkhi, and Lahcen Belyamani, and M'barek Dimou
November 2006, Emerging infectious diseases,
Mostafa Rafai, and Khalil Abouelalaa, and Yassine Skhsoukh, and Hicham Balkhi, and Lahcen Belyamani, and M'barek Dimou
January 2011, Japanese journal of infectious diseases,
Mostafa Rafai, and Khalil Abouelalaa, and Yassine Skhsoukh, and Hicham Balkhi, and Lahcen Belyamani, and M'barek Dimou
September 2012, Le infezioni in medicina,
Mostafa Rafai, and Khalil Abouelalaa, and Yassine Skhsoukh, and Hicham Balkhi, and Lahcen Belyamani, and M'barek Dimou
January 1997, Annales de dermatologie et de venereologie,
Mostafa Rafai, and Khalil Abouelalaa, and Yassine Skhsoukh, and Hicham Balkhi, and Lahcen Belyamani, and M'barek Dimou
November 2012, Annales francaises d'anesthesie et de reanimation,
Mostafa Rafai, and Khalil Abouelalaa, and Yassine Skhsoukh, and Hicham Balkhi, and Lahcen Belyamani, and M'barek Dimou
January 2017, PloS one,
Mostafa Rafai, and Khalil Abouelalaa, and Yassine Skhsoukh, and Hicham Balkhi, and Lahcen Belyamani, and M'barek Dimou
November 2020, Infectious disease reports,
Mostafa Rafai, and Khalil Abouelalaa, and Yassine Skhsoukh, and Hicham Balkhi, and Lahcen Belyamani, and M'barek Dimou
February 2012, Enfermedades infecciosas y microbiologia clinica,
Mostafa Rafai, and Khalil Abouelalaa, and Yassine Skhsoukh, and Hicham Balkhi, and Lahcen Belyamani, and M'barek Dimou
April 2007, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!